DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0023896 | Alcoholic Liver Diseases | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0006849 | Oral candidiasis | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0027651 | Neoplasms | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C4048195 | Autosomal dominant hypocalcemia | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C1306459 | Primary malignant neoplasm | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0019196 | Hepatitis C | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0010068 | Coronary heart disease | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0085409 | Polyendocrinopathies, Autoimmune | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0006118 | Brain Neoplasms | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0745103 | Hyperlipoproteinemia Type IIa | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0020626 | Hypoparathyroidism | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0677886 | Epithelial ovarian cancer | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0007131 | Non-Small Cell Lung Carcinoma | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0006826 | Malignant Neoplasms | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0008370 | Cholestasis | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0027819 | Neuroblastoma | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0700095 | Central neuroblastoma | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0948008 | Ischemic stroke | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0007134 | Renal Cell Carcinoma | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0009402 | Colorectal Carcinoma | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0006826 | Malignant Neoplasms | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0242379 | Malignant neoplasm of lung | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C1832661 | ANOPHTHALMIA AND PULMONARY HYPOPLASIA | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0006142 | Malignant neoplasm of breast | ACYP2 | 98 | acylphosphatase 2 | P14621 |
C0027651 | Neoplasms | ACYP2 | 98 | acylphosphatase 2 | P14621 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024